MACUSTAR
Dry age-related macular degeneration: Development of novel clinical endpoints for clinical trials with a regulatory and patient access intentionThe major objective is to develop novel clinical endpoints for clinical trials with a regulatory and patient access intention in patients with intermediate age-related macular degeneration (iAMD). Additional objectives are to characterise visual impairment in iAMD and its progression, as well as identify risk factors for progression to late stage AMD.
Population: adult | Intervention type: non-interventional study
Publications
Publications